Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts

Related Clinical Trial
The Performance of a Robot-assisted Minimally Invasive Direct Cochlear Access for Cochlear Implantation Auditory Performances With Different Stimulation Depths in Cochlear Implanted Subjects Using a Fine Structure Strategy Feasibility of the Mi2000 Totally Implantable Cochlear Implant in Severely to Profoundly Deaf Adults. Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study) Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss Dexamethasone-Eluting Cochlear Implant Electrode Artificial Intelligence in Diagnosis of DFNA9 Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC Cochlear Implant and Vestibular Function. Quality Control of CE-Certified Phonak Hearing Aids – 2018_42 Quality Control of CE-Certified Phonak Hearing Aids – 2018_28 Enlarged Vestibular Aqueduct Registry Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis Effectiveness of P02 Digital Hearing Aids ABR Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population Genetic Analysis of Hereditary Disorders of Hearing and Balance Compassionate Use Arm – ABI541 ABI for 10 NF2 Patients Evaluation of a Binaural Beamformer (StereoZoom) in a Virtual Acoustic Environment and in Real Life Evaluation of N6 Sound Processor in Group of Freedom Users Robotic Assisted Cochlear Implantation Feasibility Study Auditory Nerve Test System During Vestibular Schwannoma Resection Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors Listening Effort in Cochlear Implant Users Quality Control of CE-Certified Phonak Hearing Aids – 2019_19 Esteem Totally Implantable Hearing System A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease Study of Quality Perception on Music in New Cochlear Implanted Subjects Using or Not a Fine Structure Strategy An Evidence Based Delivery Model of Care for Newly Implanted Adult CI Recipients Study of Auditory Performance on Prosodic Tests in Cochlear Implanted Subjects Using a Fine Structure Strategy CI532 – Early Experience Study Clinical Applications of Round Window Imaging Anatomy in Cochlear Implant Surgery Single-sided Deafness and Cochlear Implants Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques OTO-413 in Subjects With Speech-in-Noise Hearing Impairment The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure Clinical Evaluation of a Cochlear Implant System Objective Measures in Cochlear Implant Evaluation of a Binaural Spatialization Method for Hearing Aids Esteem New Subject Enrollment Post Approval Study Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss Investigation of Anatomical Correlates of Speech Discrimination Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts Balance in Children With Cochlear Implants Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System Radiological Classification of the Facial Nerve Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial The Effect of Sound Stimulation on Hearing Ability The Effect of Sound Stimulation on Pure-tone Hearing Threshold Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss The SeaSHeL National Prospective Cohort Study Non-linear Frequency Compared to Conventional Processing in Patients With and Without Cochlear Dead Regions. Study of Low Level Laser Therapy and Word Recognition in Hearing Impaired Individuals Electrode Placement and Audiologic Outcomes With the Advanced Bionics HiFocus L23 Electrode Video HIT in Sudden Sensorineural Hearing Loss Determine the Incidence of Long QT Amongst a Large Cohort of Subjects Diagnosed With Unilateral or Bilateral Sensorineural Hearing Loss. FX-322 in Sensorineural Hearing Loss Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss FX-322 in Adults With Stable Sensorineural Hearing Loss

Brief Title

Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts

Official Title

Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts

Brief Summary

      This study will try to identify and understand the genetic factors that lead to an inner ear
      malformation called "enlarged vestibular aqueducts", that can be associated with hearing
      loss.

      Patients with sensorineural hearing loss with or without inner ear malformations and their
      parents and siblings may be eligible for this study. Participants and their immediate family
      members, may undergo some or all of the following tests and procedures:

        -  Medical and family history, including questions about hearing, balance and other
           ear-related issues, and review of medical records.

        -  Routine physical examination.

        -  Blood draw or buccal swab (brushing inside the cheek to collect cells) - Tissue is
           collected for DNA analysis to look for changes in genes that may be related to hearing
           loss.

        -  Hearing tests - The subject listens for tones emitted through a small earphone.

        -  Balance test (VEMP) to see if balance functions of the inner ear are associated with the
           hearing loss Electrodes will be placed behind your ear and at the base of your neck.
           From a reclining position, you will be asked to raise your head while clicking sounds
           are played into your ears. - Ultrasound tests - An inner ear malformation called EVA
           (enlargement of the vestibular aqueduct) indicates that a genetic disorder called
           Pendred syndrome may be the cause. Because thyroid abnormalities are also associated
           with Pendred syndrome, an ultrasound examination of the thyroid gland may be done.

        -  Computed tomography (CT) and magnetic resonance imaging (MRI) scans - These tests show
           the structure of the inner ear. For CT, the subject lies still for a short time while
           X-ray images are obtained. For MRI, the patient lies on a stretcher that is moved into a
           cylindrical machine with a strong magnetic field. The magnetic field and radio waves
           produce images of the inner ear. The radio waves cause loud thumping noises that can be
           muffled by the use of earplugs.
    

Detailed Description

      Nonsyndromic hereditary hearing impairment is a genetically heterogeneous disorder that can
      be caused by mutations in any one of at least 60 different genes. Enlargement of the
      vestibular aqueduct (EVA) is a radiologic finding known to be associated with mutations in
      one of these genes, the Pendred syndrome gene (SLC26A4, formerly known as PDS). EVA may thus
      serve as a clinically useful marker to facilitate the diagnosis of hearing impairment. Recent
      data from our laboratory and others indicates that only a subset of individuals with EVA have
      SLC26A4 mutations, and therefore some EVA cases are likely to be caused by other genes,
      nongenetic factors, or a combination of these etiologies. Families with two or more
      individuals with hearing impairment and EVA will be enrolled in this study in order to
      identify other genetic factors that cause EVA. Siblings and parents may also be enrolled in
      order to define inheritance and to perform molecular genetic analyses.
    


Study Type

Observational


Primary Outcome

By using genetic linkage, identify and map possible additional mutant alleles of SLC26A4 or other genes causing nonsyndromic EVA in patients with one or no detectable mutant allele of SLC26A4


Condition

Sensorineural Hearing Loss


Study Arms / Comparison Groups

 1
Description:  Patients with known or suspected nonsyndromic SNHL associated with EVA

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

324

Start Date

September 4, 2001



Eligibility Criteria

        -  INCLUSION CRITERIA:

        Subjects must have or be a family member of a participant with known or non-syndromic SNHL
        associated with EVA or have evidence of other findings that suggest that EVA might be part
        of a novel phenotype

        There must be at least two participating affected family members with one exception: if
        there is only one participating affected family member, there must be genetic test results
        identifying only one pathogenic mutant allele of SLC26A4

        Adults must be able to provide informed consent

        Minors must have a parent or guardian able to provide consent

        Age between 0-99.

        EXCLUSION CRITERIA:

        Subjects with known exposure to physical or chemical teratogens in utero that could account
        for their inner ear malformations such as thalidomide or radiation

        Any hearing loss that is associated with symptoms which meet the criteria of already known
        syndromes, such as, branchio-oto-renal (BOR) syndrome, which comprises system malformations
        and branchial cleft abnormalities and is caused by heterozygous mutations in the EYA1 gene.

        Previous genetic testing identifying two pathogenic mutant alleles of SLC26A4.

        Prospective study subjects who are cognitively impaired and lack consent capacity, will not
        be enrolled.
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

Thomas B Friedman, Ph.D., , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT00023036

Organization ID

010228

Secondary IDs

01-DC-0228

Responsible Party

Sponsor

Study Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)


Study Sponsor

Thomas B Friedman, Ph.D., Principal Investigator, National Institute on Deafness and Other Communication Disorders (NIDCD)


Verification Date

October 20, 2020